JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, T M
Right arrow Articles by Saverymuttu, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, T M
Right arrow Articles by Saverymuttu, S
J Clin Pathol 2001; 54:219-223
© 2001 Journal of Clinical Pathology

Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia

T M Peters1, R J Owen2, E Slater2, R Varea2, E L Teare1, S Saverymuttu3

1 Public Health Laboratory, Chelmsford CM2 0YX, UK
2 Helicobacter Reference Unit, Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK
3 Department of Gastroenterology, Broomfield Hospital, Chelmsford CM1 7ET, UK

Dr Owen rowen{at}phls.nhs.uk Aims—To investigate variation within the cag pathogenicity island (PAI) of Helicobacter pylori isolated from patients with dyspepsia in mid-Essex, and to evaluate the effect on expression of anti-CagA antibody.

Methods—Sixty two isolates of H pylori cultured from gastric biopsies were screened by specific PCR assays for the presence of cagA and other gene markers (cagD and cagE, and virD4) in the cag PAI. An enzyme linked immunosorbent assay (ELISA) kit (Viva Diagnostica helicobacter p120) was used to test for anti-CagA IgG antibody in matching sera. Isolates were also genotyped by vacuolating cytotoxin polymerase chain reaction (PCR) analysis, and tested for absence of the complete cag PAI (empty site PCR assay).

Results—Forty one of the H pylori isolates had a cag PAI containing cagA. One strain had no cagA but other cag PAI loci were present, whereas the remaining 20 strains had no detectable cag PAI markers. Anti-CagA IgG antibody was detected in 34 sera by the ELISA assay, and when compared with the cag PAI genotype of the infecting strain, accuracy, sensitivity, and specificity were 92%, 87%, and 100%, respectively. The seven discrepant or borderline strains in the ELISA were all vacA s1 but differed in other genotypic markers.

Conclusions—The cag PAI was widely distributed in H pylori from patients with dyspepsia in mid-Essex who had different gastric pathologies. Infection with a strain having an uninterrupted cag PAI was associated with the presence of anti-CagA antibody in most patients. Discrepant ELISA results, mostly for elderly patients with duodenal ulcers, were attributed to cagA associated variation, particularly to the presence of mixed cagA+/cagA- cell variants in the infecting strain population. Tests for anti-CagA serum antibody were unreliable for predicting severity of clinical disease associated with H pylori infection in this series of patients.

Key Words: Helicobacter pylori • cagA • cag pathogenicity island • CagA antibody assay




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Camorlinga-Ponce, L. Flores-Luna, E. Lazcano-Ponce, R. Herrero, F. Bernal-Sahagun, J. M. Abdo-Francis, J. Aguirre-Garcia, N. Munoz, and J. Torres
Age and Severity of Mucosal Lesions Influence the Performance of Serologic Markers in Helicobacter pylori-Associated Gastroduodenal Pathologies
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2498 - 2504.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
F. Kauser, A. A. Khan, M. A. Hussain, I. M. Carroll, N. Ahmad, S. Tiwari, Y. Shouche, B. Das, M. Alam, S. M. Ali, et al.
The cag Pathogenicity Island of Helicobacter pylori Is Disrupted in the Majority of Patient Isolates from Different Human Populations
J. Clin. Microbiol., November 1, 2004; 42(11): 5302 - 5308.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Backert, T. Schwarz, S. Miehlke, C. Kirsch, C. Sommer, T. Kwok, M. Gerhard, U. B. Goebel, N. Lehn, W. Koenig, et al.
Functional Analysis of the cag Pathogenicity Island in Helicobacter pylori Isolates from Patients with Gastritis, Peptic Ulcer, and Gastric Cancer
Infect. Immun., February 1, 2004; 72(2): 1043 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Nilsson, A. Sillen, L. Eriksson, M.-L. Strand, H. Enroth, S. Normark, P. Falk, and L. Engstrand
Correlation between cag Pathogenicity Island Composition and Helicobacter pylori-Associated Gastroduodenal Disease
Infect. Immun., November 1, 2003; 71(11): 6573 - 6581.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
R. J. Owen, S. I. Sharp, S. A. Chisholm, and S. Rijpkema
Identification of cagA Tyrosine Phosphorylation DNA Motifs in Helicobacter pylori Isolates from Peptic Ulcer Patients by Novel PCR-Restriction Fragment Length Polymorphism and Real-Time Fluorescence PCR Assays
J. Clin. Microbiol., July 1, 2003; 41(7): 3112 - 3118.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. L. Tomasini, S. Zanussi, M. Sozzi, R. Tedeschi, G. Basaglia, and P. De Paoli
Heterogeneity of cag Genotypes in Helicobacterpylori Isolates from Human Biopsy Specimens
J. Clin. Microbiol., March 1, 2003; 41(3): 976 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P J van Diest and H Holzel
Cervical cancer
J. Clin. Pathol., April 1, 2002; 55(4): 241 - 242.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.